Olema Pharmaceuticals Inc OLMA Q1 2026 Earnings NarrowerThanExpected Loss Amid Ongoing Clinical Progress ADUS Q1 2026 Earnings EPS Beats Estimates by 242 Stock Edges Lower SEE Q4 2025 Earnings EPS Beats Estimates by 428 as Operational Efficiency Drives Results GCBC Q2 2025 Earnings Solid EPS of 044 Despite Absence of Consensus Estimates MFIN Q1 2026 Earnings Earnings Miss Weighs on Stock PMTV Q1 2026 Earnings Persistent Headwinds Trigger Significant EPS Miss